SAB Biotherapeutics, Inc. (NASDAQ:SABSW) Short Interest Update

SAB Biotherapeutics, Inc. (NASDAQ:SABSW) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 13,700 shares, an increase of 585.0% from the March 15th total of 2,000 shares. Based on an average daily trading volume, of 25,700 shares, the days-to-cover ratio is currently 0.5 days.

SAB Biotherapeutics Price Performance

Shares of NASDAQ SABSW traded down $0.00 during trading on Wednesday, hitting $0.02. 1,200 shares of the company traded hands, compared to its average volume of 22,716. SAB Biotherapeutics has a fifty-two week low of $0.01 and a fifty-two week high of $0.18. The business’s fifty day moving average is $0.03 and its 200 day moving average is $0.05.

About SAB Biotherapeutics

SAB Biotherapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases.